Evidence map›Paper›PMID 24350100›Full record

ReviewNephro-urology monthly2013

Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction.

Mohammad Sajjad Rahnama'i, Gommert A Van Koeveringe, Philip E Van Kerrebroeck

Open access · hybridAbstract readReview
In one paragraph

Review in Nephro-urology monthly, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neuromodulation for functional bladder disorders in patients with multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Avanafil Inhibits the Contractility of the Isolated Caprine Detrusor Muscle.International journal of applied & basic medical research
    Article
  12. PATTERN OF OVERACTIVE BLADDER IN SOUTHEAST NIGERIA.Journal of the West African College of Surgeons
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammad Sajjad Rahnama'iMaastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
Gommert A Van KoeveringeMaastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
Philip E Van KerrebroeckMaastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.
Maastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, a general introduction is given, presenting the overactive bladder syndrome (OAB) and its impact on the quality of life and economical burden in patients affected. Moreover, the anatomy, physiology and histology of the lower urinary tract are discussed, followed by a brief overview on the possible role of prostaglandin (PG) and phosphodiesterase type 5 (PDE5) in the urinary bladder. The current literature on the role and distribution of PGE2 and its receptors in the urinary bladder is discussed. In both animal models and in human studies, high levels of signaling molecules such as PG and cGMP have been implicated, in decreased functional bladder capacity and micturition volume, as well as in increased voiding contraction amplitude. As a consequence, inhibition of prostanoid production, the use of prostanoid receptor antagonists, or PDE inhibitors might be a rational way to treat patients with detrusor overactivity. Similarly, prostanoid receptor agonists, or agents that stimulate their production, might have a function in treating bladder underactivity.

Indexed as

Phosphodiesetrase Type 5ProstaglandinsUrinary BladderUrinary Bladder, Overactive

Identifiers

PMID24350100
PMCPMC3842572
OpenAlexW1980903351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.